Research Grant Awards - Fanconi Cancer Foundation
Supports innovative research on Fanconi anemia, focusing on disease mechanisms, therapies, prevention, gene editing, biomarkers, and quality of life improvements.
Browse similar grants
This grant is no longer accepting proposals
Fanconi Cancer Foundation has archived this opportunity.
Funder: Fanconi Cancer Foundation
Due Dates: March 6, 2026 (LOI deadline) | June 5, 2026 (Full proposal deadline)
Funding Amounts: $25,000–$250,000 per project for 1–2 years; milestone-based payments; no indirect costs
Summary: Supports innovative research on Fanconi anemia, emphasizing disease mechanisms, therapies, prevention, and quality of life.
Key Information: Preliminary data not required but strengthens applications; both preclinical and clinical projects eligible.
Description
The Fanconi Cancer Foundation (FCF) Research Grant Awards support interdisciplinary and translational research projects that advance the understanding, prevention, detection, treatment, or cure of Fanconi anemia (FA). The program encourages both preclinical and clinical studies, with a focus on projects that address FCF’s core priorities: defining cancer pathogenesis in FA, developing prevention and treatment strategies, advancing gene therapy and gene editing, identifying predictors and treatments for bone marrow failure, understanding systemic and aging manifestations, improving quality of life, leveraging data analytics for biomarker discovery, and creating shared research resources. The Foundation seeks innovative proposals with the potential for significant impact, particularly those that may not be funded by larger federal agencies.
